State Street’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152K Buy
49,239
+18,400
+60% +$62.4K ﹤0.01% 3895
2026
Q1
$129K Buy
30,839
+1,150
+4% +$4.8K ﹤0.01% 3982
2025
Q4
$128K Sell
29,689
-1,350
-4% -$5.15K ﹤0.01% 3996
2025
Q3
$135K Buy
31,039
+10,839
+54% +$48.9K ﹤0.01% 3996
2025
Q2
$93.7K Buy
+20,200
New +$79.9K ﹤0.01% 3987

Other funds holding SBC

State Street's SBC Position: Q2 2026 in Review

State Street increased its SBC Medical Group (SBC) stake by 60% in Q2 2026, buying an estimated $62.4K and bringing the position to 49,239 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #3895.

State Street first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • State Street held 49,239 shares of SBC Medical Group worth $152K as of Q2 2026.
  • State Street bought 18,400 SBC Medical Group shares in Q2 2026, an estimated $62.4K.
  • SBC Medical Group made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3895 holding.
  • State Street first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.